Who to call at Novavax, and when

Fundz watches for the moments Novavax starts buying, and tells you who to reach.

An alert the day Novavax raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Novavax, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Novavax. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Novavax Secures $125 Million Milestone Payment from Sanofi

Oct 30, 2026

Gaithersburg

Description

On October 28, 2026, Novavax announced that its partner Sanofi Pasteur Inc. dosed the fifth patient in a Phase 3 trial for a combination influenza-COVID-19 vaccine. This milestone has triggered a $125 million payment under Novavax's Collaboration and License Agreement with Sanofi. The company expects to receive this payment by the first quarter of 2027

Company Information

Company

Novavax

Location

Gaithersburg, Maryland, United States

About

We’re making a difference in the health of people around the world by producing next generation vaccines that are accessible to more people. We stand strong against infectious diseases and viral threats—our science grounds us, our technology pushes us forward, our commitment inspires us to achieve our hopes. We do this work for the greater health of people everywhere. It’s more than our job. It’s our passion.